OSA-PG enhanced the phagocytosis activity of macrophages and increased the production of IL-6 and TNF-α by elevating the gene expression levels in both J774.1 cells and peritoneal macrophages. The gene discussed is IL6; the disease is obstructive sleep apnea syndrome.